Dr. Lublin describes the latest data presented at ECTRIMS on additional emerging MS therapies (firategrast, cladribine, alemtuzumab, daclizumab, laquinimod, BG00012).
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More